Craig Leonardi
Dermatology · Saint Louis, MONPI 1477626869
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $355,568 of the $569,106 with a category attached, or 62.5%. 27 manufacturers reported payments, led by Lilly USA, LLC at 29.0% of the total. Reporting peaked in 2019 at $241,024 and has fallen 99.0% since, to $2,363 in 2024. Among dermatology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,048 payments — averaging $543.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$165K
- AbbVie$81K
- Novartis$77K
- UCB, Inc.$65K
- Janssen Scientific Affairs, LLC$55K
- Amgen$37K
- plus $89K from 21 others
Across 238 payments — averaging $4702.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$333K
- AbbVie$267K
- Eli Lilly$220K
- Janssen Research & Development, LLC$146K
- Amgen$127K
- Bristol Myers Squibb$11K
- plus $14K from 5 others
What the payments were for
- Consulting fees$169,04730%
- Speaking & faculty fees$355,56862%
- Grants$870%
- Travel & lodging$24,8604%
- Food & beverage$19,0623%
- Education$4830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 172 | $165,108 |
| AbbVie | 215 | $80,794 |
| Novartis | 121 | $76,522 |
| UCB, Inc. | 100 | $65,057 |
| Janssen Scientific Affairs, LLC | 45 | $55,239 |
| Amgen | 121 | $36,954 |
| Eli Lilly | 8 | $18,694 |
| Johnson & Johnson(2 entities) | 84 | $17,990 |
| UCB SA | 10 | $11,548 |
| Boehringer Ingelheim International GmbH | 7 | $9,807 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 32 | $8,543 |
| Bristol Myers Squibb | 30 | $8,328 |
| E.r. Squibb & Sons, L.L.C. | 14 | $7,115 |
| Sun Pharmaceutical Industries Inc. | 21 | $3,462 |
| Boehringer Ingelheim | 3 | $2,532 |
| LEO Pharma Inc. | 22 | $518 |
| Pfizer | 12 | $297 |
| Regeneron Healthcare Solutions, Inc. | 12 | $284 |
| Galderma Laboratories, L.p. | 5 | $94 |
| Sanofi | 4 | $60 |
| Incyte Corporation | 3 | $55 |
| Journey Medical Corporation | 2 | $32 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| AstraZeneca | 1 | $19 |
| EPI Health, LLC | 1 | $14 |
| Almirall LLC | 1 | $14 |
| Merck | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$569,106 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.
Other dermatology in Saint Louis
- Brian KimSaint Louis$861K
- Elaine SiegfriedSaint Louis$856K
- Mary GeorgeSaint Louis$400K
- Duane DilworthSaint Louis$288K
- Jeffrey ReedSaint Louis$170K
- Emily ColeSaint Louis$163K
- Dee GlaserSaint Louis$131K
- Milan AnadkatSaint Louis$129K
- Jason AmatoSaint Louis$45K
- Amy MusiekSaint Louis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.